Parkinson disease, the effect of levodopa, and the ELLDOPA trial. Earlier vs Later L-DOPA

Arch Neurol. 1999 May;56(5):529-35. doi: 10.1001/archneur.56.5.529.
No abstract available

Publication types

  • Review

MeSH terms

  • Antiparkinson Agents / adverse effects
  • Antiparkinson Agents / pharmacology
  • Antiparkinson Agents / therapeutic use*
  • Clinical Trials as Topic
  • Evidence-Based Medicine
  • Humans
  • Levodopa / adverse effects
  • Levodopa / pharmacology
  • Levodopa / therapeutic use*
  • Neurology / trends
  • Outcome Assessment, Health Care
  • Parkinson Disease / drug therapy*
  • Practice Patterns, Physicians'

Substances

  • Antiparkinson Agents
  • Levodopa